context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
On May 3, 2024, the 2024 Long-Term Incentive Plan (the "2024 Plan") was approved by shareholders, and became effective on June 30, 2024 (the "Effective Date"). Subsequent to the Effective Date, no additional awards will be granted to employees under the 2015 Long-Term Incentive Plan (the "2015 Plan"). The 2024 Plan allows for the issuance of up to 11.5 million shares of ITW common stock for awards granted under the plan, of which 3.5 million shares were subject to awards outstanding under the 2015 Plan as of the Effective Date and are available for rollover should the awards expire, terminate or be forfeited. The significant terms of stock options and restricted stock units ("RSUs") were not changed under the 2024 Plan. Stock options and RSUs are issued to officers and/or other management employees under these plans. Stock options generally vest over a four-year period and have an expiration of ten years from the issuance date. RSUs generally "cliff" vest after a three-year period and include units with and without performance criteria. RSUs with performance criteria provide for full "cliff" vesting after three years if the Compensation Committee of the Board of Directors certifies that the performance goals have been met. Upon vesting, the holder will receive one share of common stock of the Company for each vested restricted stock unit. | text | 11.5 | sharesItemType | text: <entity> 11.5 </entity> <entity type> sharesItemType </entity type> <context> On May 3, 2024, the 2024 Long-Term Incentive Plan (the "2024 Plan") was approved by shareholders, and became effective on June 30, 2024 (the "Effective Date"). Subsequent to the Effective Date, no additional awards will be granted to employees under the 2015 Long-Term Incentive Plan (the "2015 Plan"). The 2024 Plan allows for the issuance of up to 11.5 million shares of ITW common stock for awards granted under the plan, of which 3.5 million shares were subject to awards outstanding under the 2015 Plan as of the Effective Date and are available for rollover should the awards expire, terminate or be forfeited. The significant terms of stock options and restricted stock units ("RSUs") were not changed under the 2024 Plan. Stock options and RSUs are issued to officers and/or other management employees under these plans. Stock options generally vest over a four-year period and have an expiration of ten years from the issuance date. RSUs generally "cliff" vest after a three-year period and include units with and without performance criteria. RSUs with performance criteria provide for full "cliff" vesting after three years if the Compensation Committee of the Board of Directors certifies that the performance goals have been met. Upon vesting, the holder will receive one share of common stock of the Company for each vested restricted stock unit. </context> | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
On May 3, 2024, the 2024 Long-Term Incentive Plan (the "2024 Plan") was approved by shareholders, and became effective on June 30, 2024 (the "Effective Date"). Subsequent to the Effective Date, no additional awards will be granted to employees under the 2015 Long-Term Incentive Plan (the "2015 Plan"). The 2024 Plan allows for the issuance of up to 11.5 million shares of ITW common stock for awards granted under the plan, of which 3.5 million shares were subject to awards outstanding under the 2015 Plan as of the Effective Date and are available for rollover should the awards expire, terminate or be forfeited. The significant terms of stock options and restricted stock units ("RSUs") were not changed under the 2024 Plan. Stock options and RSUs are issued to officers and/or other management employees under these plans. Stock options generally vest over a four-year period and have an expiration of ten years from the issuance date. RSUs generally "cliff" vest after a three-year period and include units with and without performance criteria. RSUs with performance criteria provide for full "cliff" vesting after three years if the Compensation Committee of the Board of Directors certifies that the performance goals have been met. Upon vesting, the holder will receive one share of common stock of the Company for each vested restricted stock unit. | text | 3.5 | sharesItemType | text: <entity> 3.5 </entity> <entity type> sharesItemType </entity type> <context> On May 3, 2024, the 2024 Long-Term Incentive Plan (the "2024 Plan") was approved by shareholders, and became effective on June 30, 2024 (the "Effective Date"). Subsequent to the Effective Date, no additional awards will be granted to employees under the 2015 Long-Term Incentive Plan (the "2015 Plan"). The 2024 Plan allows for the issuance of up to 11.5 million shares of ITW common stock for awards granted under the plan, of which 3.5 million shares were subject to awards outstanding under the 2015 Plan as of the Effective Date and are available for rollover should the awards expire, terminate or be forfeited. The significant terms of stock options and restricted stock units ("RSUs") were not changed under the 2024 Plan. Stock options and RSUs are issued to officers and/or other management employees under these plans. Stock options generally vest over a four-year period and have an expiration of ten years from the issuance date. RSUs generally "cliff" vest after a three-year period and include units with and without performance criteria. RSUs with performance criteria provide for full "cliff" vesting after three years if the Compensation Committee of the Board of Directors certifies that the performance goals have been met. Upon vesting, the holder will receive one share of common stock of the Company for each vested restricted stock unit. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber |
The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. | text | 68.98 | perShareItemType | text: <entity> 68.98 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. | text | 67.16 | perShareItemType | text: <entity> 67.16 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. | text | 45.15 | perShareItemType | text: <entity> 45.15 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. | text | 55 | monetaryItemType | text: <entity> 55 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. | text | 79 | monetaryItemType | text: <entity> 79 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. | text | 38 | monetaryItemType | text: <entity> 38 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. | text | 52 | monetaryItemType | text: <entity> 52 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. </context> | us-gaap:ProceedsFromStockOptionsExercised |
The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. | text | 53 | monetaryItemType | text: <entity> 53 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. </context> | us-gaap:ProceedsFromStockOptionsExercised |
The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. | text | 29 | monetaryItemType | text: <entity> 29 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. </context> | us-gaap:ProceedsFromStockOptionsExercised |
The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. | text | 18 | monetaryItemType | text: <entity> 18 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of stock options granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 68.98 , $ 67.16 and $ 45.15 per share, respectively. The aggregate intrinsic value of stock options exercised during the twelve months ended December 31, 2024, 2023 and 2022 was $ 55 million, $ 79 million and $ 38 million, respectively. Exercise of stock options during the twelve months ended December 31, 2024, 2023 and 2022 resulted in cash receipts of $ 52 million, $ 53 million and $ 29 million, respectively. The total fair value of vested stock option awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 18 million, $ 18 million and $ 18 million, respectively. As of December 31, 2024, there was $ 11 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.0 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. | text | 243.77 | perShareItemType | text: <entity> 243.77 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. | text | 232.21 | perShareItemType | text: <entity> 232.21 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. | text | 215.36 | perShareItemType | text: <entity> 215.36 </entity> <entity type> perShareItemType </entity type> <context> The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. | text | 52 | monetaryItemType | text: <entity> 52 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. | text | 28 | monetaryItemType | text: <entity> 28 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. | text | 47 | monetaryItemType | text: <entity> 47 </entity> <entity type> monetaryItemType </entity type> <context> The weighted-average grant-date fair value of RSU awards granted for the twelve months ended December 31, 2024, 2023 and 2022 was $ 243.77 , $ 232.21 and $ 215.36 , respectively. The total grant-date fair value of vested RSU awards during the twelve months ended December 31, 2024, 2023 and 2022 was $ 52 million, $ 35 million and $ 28 million, respectively. As of December 31, 2024, there was $ 47 million of total unrecognized compensation cost related to unvested RSUs. That cost is expected to be recognized over a weighted-average remaining contractual life of 1.7 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
The Company's operations are organized and managed based on similar product offerings and end markets, and are reported to senior management as the following seven segments: Automotive OEM; Food Equipment; Test & Measurement and Electronics; Welding; Polymers & Fluids; Construction Products; and Specialty Products. The following is a description of the Company's seven segments: | text | seven | integerItemType | text: <entity> seven </entity> <entity type> integerItemType </entity type> <context> The Company's operations are organized and managed based on similar product offerings and end markets, and are reported to senior management as the following seven segments: Automotive OEM; Food Equipment; Test & Measurement and Electronics; Welding; Polymers & Fluids; Construction Products; and Specialty Products. The following is a description of the Company's seven segments: </context> | us-gaap:NumberOfReportableSegments |
Unallocated expenses in 2024 included the favorable pre-tax cumulative effect of the LIFO accounting method change of $ 117 million in the first quarter of 2024. Refer to Note 1. Description of Business and Summary of Significant Accounting Policies for additional information regarding this change in accounting method. | text | 117 | monetaryItemType | text: <entity> 117 </entity> <entity type> monetaryItemType </entity type> <context> Unallocated expenses in 2024 included the favorable pre-tax cumulative effect of the LIFO accounting method change of $ 117 million in the first quarter of 2024. Refer to Note 1. Description of Business and Summary of Significant Accounting Policies for additional information regarding this change in accounting method. </context> | us-gaap:OperatingIncomeLoss |
Operating revenue by geographic region is based on the customers' locations. The Company had approximately 44 % and 44 % of its total net plant and equipment in the United States as of December 31, 2024 and 2023, respectively. Additionally, the Company had 16 % and 13 % of its total net plant and equipment in China as of December 31, 2024 and 2023, respectively. No other country represented more than 10% of the Company's net plant and equipment as of December 31, | text | 44 | percentItemType | text: <entity> 44 </entity> <entity type> percentItemType </entity type> <context> Operating revenue by geographic region is based on the customers' locations. The Company had approximately 44 % and 44 % of its total net plant and equipment in the United States as of December 31, 2024 and 2023, respectively. Additionally, the Company had 16 % and 13 % of its total net plant and equipment in China as of December 31, 2024 and 2023, respectively. No other country represented more than 10% of the Company's net plant and equipment as of December 31, </context> | us-gaap:ConcentrationRiskPercentage1 |
Operating revenue by geographic region is based on the customers' locations. The Company had approximately 44 % and 44 % of its total net plant and equipment in the United States as of December 31, 2024 and 2023, respectively. Additionally, the Company had 16 % and 13 % of its total net plant and equipment in China as of December 31, 2024 and 2023, respectively. No other country represented more than 10% of the Company's net plant and equipment as of December 31, | text | 16 | percentItemType | text: <entity> 16 </entity> <entity type> percentItemType </entity type> <context> Operating revenue by geographic region is based on the customers' locations. The Company had approximately 44 % and 44 % of its total net plant and equipment in the United States as of December 31, 2024 and 2023, respectively. Additionally, the Company had 16 % and 13 % of its total net plant and equipment in China as of December 31, 2024 and 2023, respectively. No other country represented more than 10% of the Company's net plant and equipment as of December 31, </context> | us-gaap:ConcentrationRiskPercentage1 |
Operating revenue by geographic region is based on the customers' locations. The Company had approximately 44 % and 44 % of its total net plant and equipment in the United States as of December 31, 2024 and 2023, respectively. Additionally, the Company had 16 % and 13 % of its total net plant and equipment in China as of December 31, 2024 and 2023, respectively. No other country represented more than 10% of the Company's net plant and equipment as of December 31, | text | 13 | percentItemType | text: <entity> 13 </entity> <entity type> percentItemType </entity type> <context> Operating revenue by geographic region is based on the customers' locations. The Company had approximately 44 % and 44 % of its total net plant and equipment in the United States as of December 31, 2024 and 2023, respectively. Additionally, the Company had 16 % and 13 % of its total net plant and equipment in China as of December 31, 2024 and 2023, respectively. No other country represented more than 10% of the Company's net plant and equipment as of December 31, </context> | us-gaap:ConcentrationRiskPercentage1 |
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. | text | 18576527 | sharesItemType | text: <entity> 18576527 </entity> <entity type> sharesItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context> | us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction |
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. | text | 3300000 | sharesItemType | text: <entity> 3300000 </entity> <entity type> sharesItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context> | us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction |
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. | text | 6723473 | sharesItemType | text: <entity> 6723473 </entity> <entity type> sharesItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context> | us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction |
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. | text | 34.00 | perShareItemType | text: <entity> 34.00 </entity> <entity type> perShareItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context> | us-gaap:SaleOfStockPricePerShare |
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. | text | 600.0 | monetaryItemType | text: <entity> 600.0 </entity> <entity type> monetaryItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context> | us-gaap:ProceedsFromIssuanceInitialPublicOffering |
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. | text | 67917432 | sharesItemType | text: <entity> 67917432 </entity> <entity type> sharesItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context> | us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities |
On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. | text | 5104017 | sharesItemType | text: <entity> 5104017 </entity> <entity type> sharesItemType </entity type> <context> On March 20, 2024, our initial public offering (“IPO”) was declared effective and our Class A common stock began trading on the New York Stock Exchange on March 21, 2024. On March 25, 2024, we completed our IPO in which we issued and sold 18,576,527 shares of Class A common stock, including 3,300,000 shares of Class A common stock pursuant to the underwriters’ exercise in full of their over-allotment option, and excluding 6,723,473 shares of Class A common stock sold in the IPO by certain of our existing stockholders, at a public offering price of $ 34.00 per share. We received net proceeds of $ 600.0 million after deducting underwriting discounts and commissions of $ 31.6 million. In connection with the closing of the IPO, all shares of our then-outstanding convertible preferred stock other than Series F-1 preferred stock automatically converted into an aggregate of 67,917,432 shares of Class B common stock and all then-outstanding shares of Series F-1 preferred stock automatically converted into 5,104,017 shares of Class A common stock. Following the IPO, we have three classes of authorized common stock — Class A common stock, Class B common stock, and Class C common stock. </context> | us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities |
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. | text | 534.7 | monetaryItemType | text: <entity> 534.7 </entity> <entity type> monetaryItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost |
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. | text | 4861113 | sharesItemType | text: <entity> 4861113 </entity> <entity type> sharesItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context> | us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation |
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. | text | 10502390 | sharesItemType | text: <entity> 10502390 </entity> <entity type> sharesItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context> | us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross |
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. | text | 723341 | sharesItemType | text: <entity> 723341 </entity> <entity type> sharesItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context> | us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation |
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. | text | 1347456 | sharesItemType | text: <entity> 1347456 </entity> <entity type> sharesItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context> | us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross |
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. | text | 34.00 | perShareItemType | text: <entity> 34.00 </entity> <entity type> perShareItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context> | us-gaap:SaleOfStockPricePerShare |
Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. | text | 189.9 | monetaryItemType | text: <entity> 189.9 </entity> <entity type> monetaryItemType </entity type> <context> Certain of our restricted stock units granted to employees included both service-based and performance-based vesting conditions (“Double Trigger RSUs”). The performance condition related to these awards was satisfied upon the effectiveness of the IPO. Upon the effectiveness of the IPO, we recognized $ 534.7 million of stock-based compensation expense. To meet the related tax withholding requirements, we withheld 4,861,113 shares of the 10,502,390 shares of Class A common stock issued and 723,341 shares of the 1,347,456 shares of Class B common stock issued. Based on the IPO public offering price of $ 34.00 per share, the tax withholding obligation was $ 189.9 million. </context> | us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation |
In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. | text | 2000000000 | sharesItemType | text: <entity> 2000000000 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. </context> | us-gaap:CommonStockSharesAuthorized |
In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. | text | 140000000 | sharesItemType | text: <entity> 140000000 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. </context> | us-gaap:CommonStockSharesAuthorized |
In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. | text | 100000000 | sharesItemType | text: <entity> 100000000 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. </context> | us-gaap:CommonStockSharesAuthorized |
In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. | text | 100000000 | sharesItemType | text: <entity> 100000000 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, we amended and restated our certificate of incorporation (“Restated Certificate”) which authorized 2,340,000,000 shares of capital stock, consisting of 2,000,000,000 shares of Class A common stock, 140,000,000 shares of Class B common stock, 100,000,000 shares of Class C common stock, and 100,000,000 shares of undesignated preferred stock. </context> | us-gaap:PreferredStockSharesAuthorized |
Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively. | text | 9.2 | monetaryItemType | text: <entity> 9.2 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively. </context> | us-gaap:AdvertisingExpense |
Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively. | text | 8.2 | monetaryItemType | text: <entity> 8.2 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively. </context> | us-gaap:AdvertisingExpense |
Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively. | text | 34.4 | monetaryItemType | text: <entity> 34.4 </entity> <entity type> monetaryItemType </entity type> <context> Advertising costs are expensed as incurred and were $ 9.2 million, $ 8.2 million, and $ 34.4 million for the years ended December 31, 2024, 2023, and 2022 respectively. </context> | us-gaap:AdvertisingExpense |
Prior to our IPO, deferred offering costs, which consisted of direct incremental legal, accounting, consulting, and other fees related to the IPO, were capitalized in other noncurrent assets on the consolidated balance sheets. After the IPO, the deferred offering costs were reclassified into additional paid-in capital as an offset against IPO proceeds. Deferred offering costs included in other noncurrent assets were $ 16.5 million as of December 31, 2023. | text | 16.5 | monetaryItemType | text: <entity> 16.5 </entity> <entity type> monetaryItemType </entity type> <context> Prior to our IPO, deferred offering costs, which consisted of direct incremental legal, accounting, consulting, and other fees related to the IPO, were capitalized in other noncurrent assets on the consolidated balance sheets. After the IPO, the deferred offering costs were reclassified into additional paid-in capital as an offset against IPO proceeds. Deferred offering costs included in other noncurrent assets were $ 16.5 million as of December 31, 2023. </context> | us-gaap:DeferredCostsCurrentAndNoncurrent |
Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. | text | 14.9 | monetaryItemType | text: <entity> 14.9 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. </context> | us-gaap:ContractWithCustomerLiability |
Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. | text | 7.4 | monetaryItemType | text: <entity> 7.4 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. </context> | us-gaap:ContractWithCustomerLiability |
Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. | text | 7.2 | monetaryItemType | text: <entity> 7.2 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. | text | 7.8 | monetaryItemType | text: <entity> 7.8 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. | text | 6.5 | monetaryItemType | text: <entity> 6.5 </entity> <entity type> monetaryItemType </entity type> <context> Deferred revenue was $ 14.9 million and $ 7.4 million as of December 31, 2024 and December 31, 2023, respectively. For the years ended December 31, 2024, 2023, and 2022, revenue recognized from the deferred revenue balance at the beginning of each period was $ 7.2 million, $ 7.8 million, and $ 6.5 million, respectively. </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. | text | 252.9 | monetaryItemType | text: <entity> 252.9 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. </context> | us-gaap:RevenueRemainingPerformanceObligation |
As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. | text | 114.6 | monetaryItemType | text: <entity> 114.6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. </context> | us-gaap:RevenueRemainingPerformanceObligation |
As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. | text | 113.2 | monetaryItemType | text: <entity> 113.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. </context> | us-gaap:RevenueRemainingPerformanceObligation |
As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. | text | 25.1 | monetaryItemType | text: <entity> 25.1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the aggregate amount of remaining performance obligations in contracts with an original expected duration exceeding one year is $ 252.9 million. This amount consists primarily of long-term content licensing contracts and excludes deferred revenue related to short-term advertising contracts and Reddit Premium subscriptions. We expect to recognize $ 114.6 million in 2025, $ 113.2 million in 2026, and $ 25.1 million in 2027. </context> | us-gaap:RevenueRemainingPerformanceObligation |
We compute net income (loss) per share of Class A and Class B common stock using the two-class method required for multiple classes of common stock and participating securities. Prior to the IPO, our participating securities included Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock, as the holders of these series of preferred stock were entitled to receive noncumulative dividends subject to certain requirements at an annual rate of 8 % of the respective original issue price then in effect in the event that a dividend was paid on common stock. | text | 8 | percentItemType | text: <entity> 8 </entity> <entity type> percentItemType </entity type> <context> We compute net income (loss) per share of Class A and Class B common stock using the two-class method required for multiple classes of common stock and participating securities. Prior to the IPO, our participating securities included Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock, as the holders of these series of preferred stock were entitled to receive noncumulative dividends subject to certain requirements at an annual rate of 8 % of the respective original issue price then in effect in the event that a dividend was paid on common stock. </context> | us-gaap:PreferredStockDividendRatePercentage |
In connection with our IPO, our Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, and Series F preferred stock converted on a one -to-one basis into 67,917,432 shares of Class B common stock, and our Series F-1 preferred stock converted on a one -to-one basis into 5,104,017 shares of Class A common stock. These shares are weighted in the denominator of net income (loss) per share for Class A and Class B common stock for the portion of the time outstanding subsequent to our IPO. | text | 67917432 | sharesItemType | text: <entity> 67917432 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, our Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, and Series F preferred stock converted on a one -to-one basis into 67,917,432 shares of Class B common stock, and our Series F-1 preferred stock converted on a one -to-one basis into 5,104,017 shares of Class A common stock. These shares are weighted in the denominator of net income (loss) per share for Class A and Class B common stock for the portion of the time outstanding subsequent to our IPO. </context> | us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities |
In connection with our IPO, our Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, and Series F preferred stock converted on a one -to-one basis into 67,917,432 shares of Class B common stock, and our Series F-1 preferred stock converted on a one -to-one basis into 5,104,017 shares of Class A common stock. These shares are weighted in the denominator of net income (loss) per share for Class A and Class B common stock for the portion of the time outstanding subsequent to our IPO. | text | 5104017 | sharesItemType | text: <entity> 5104017 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, our Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, and Series F preferred stock converted on a one -to-one basis into 67,917,432 shares of Class B common stock, and our Series F-1 preferred stock converted on a one -to-one basis into 5,104,017 shares of Class A common stock. These shares are weighted in the denominator of net income (loss) per share for Class A and Class B common stock for the portion of the time outstanding subsequent to our IPO. </context> | us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities |
As of December 31, 2024, the amortized cost of marketable securities with maturities less than one year was $ 989.2 million. The amortized cost of marketable securities with maturities between one and five years was $ 288.4 million. | text | 989.2 | monetaryItemType | text: <entity> 989.2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the amortized cost of marketable securities with maturities less than one year was $ 989.2 million. The amortized cost of marketable securities with maturities between one and five years was $ 288.4 million. </context> | us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost |
As of December 31, 2024, the amortized cost of marketable securities with maturities less than one year was $ 989.2 million. The amortized cost of marketable securities with maturities between one and five years was $ 288.4 million. | text | 288.4 | monetaryItemType | text: <entity> 288.4 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the amortized cost of marketable securities with maturities less than one year was $ 989.2 million. The amortized cost of marketable securities with maturities between one and five years was $ 288.4 million. </context> | us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost |
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 4.7 | monetaryItemType | text: <entity> 4.7 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability |
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 12.0 | monetaryItemType | text: <entity> 12.0 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability |
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 16.4 | monetaryItemType | text: <entity> 16.4 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability |
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 5.3 | monetaryItemType | text: <entity> 5.3 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:OperatingLeasePayments |
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 8.9 | monetaryItemType | text: <entity> 8.9 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:OperatingLeasePayments |
Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 9.6 | monetaryItemType | text: <entity> 9.6 </entity> <entity type> monetaryItemType </entity type> <context> Right-of-use assets obtained in exchange for lease liabilities were $ 4.7 million, $ 12.0 million, and $ 16.4 million for the years ended December 31, 2024, 2023, and 2022, respectively. Cash payments included in the measurement of our operating lease liabilities were $ 5.3 million, $ 8.9 million, and $ 9.6 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:OperatingLeasePayments |
On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services. | text | 19.9 | monetaryItemType | text: <entity> 19.9 </entity> <entity type> monetaryItemType </entity type> <context> On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services. </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services. | text | 17.1 | monetaryItemType | text: <entity> 17.1 </entity> <entity type> monetaryItemType </entity type> <context> On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services. </context> | us-gaap:PaymentsToAcquireBusinessesGross |
On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services. | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> On July 15, 2024, we completed an acquisition to enhance our technology and workforce. The aggregate purchase consideration was $ 19.9 million, which consisted of $ 17.1 million of cash consideration and $ 2.8 million related to the fair value of equity consideration. Additional consideration with a fair value of $ 10.7 million was determined to relate to post-combination expenses, primarily stock-based compensation for future employment services. </context> | us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable |
Of the aggregate purchase consideration, $ 4.3 million was allocated to developed technology with a useful life of three years , $ 15.9 million was allocated to goodwill, and the remainder was allocated to other assets acquired and liabilities assumed. | text | 4.3 | monetaryItemType | text: <entity> 4.3 </entity> <entity type> monetaryItemType </entity type> <context> Of the aggregate purchase consideration, $ 4.3 million was allocated to developed technology with a useful life of three years , $ 15.9 million was allocated to goodwill, and the remainder was allocated to other assets acquired and liabilities assumed. </context> | us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles |
Of the aggregate purchase consideration, $ 4.3 million was allocated to developed technology with a useful life of three years , $ 15.9 million was allocated to goodwill, and the remainder was allocated to other assets acquired and liabilities assumed. | text | 15.9 | monetaryItemType | text: <entity> 15.9 </entity> <entity type> monetaryItemType </entity type> <context> Of the aggregate purchase consideration, $ 4.3 million was allocated to developed technology with a useful life of three years , $ 15.9 million was allocated to goodwill, and the remainder was allocated to other assets acquired and liabilities assumed. </context> | us-gaap:Goodwill |
Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022. | text | 9.2 | monetaryItemType | text: <entity> 9.2 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022. </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022. | text | 9.0 | monetaryItemType | text: <entity> 9.0 </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022. </context> | us-gaap:AmortizationOfIntangibleAssets |
Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022. | text | immaterial | monetaryItemType | text: <entity> immaterial </entity> <entity type> monetaryItemType </entity type> <context> Amortization expense was $ 9.2 million and $ 9.0 million for the years ended December 31, 2024 and 2023, respectively. Amortization expense was immaterial for the year ended December 31, 2022. </context> | us-gaap:AmortizationOfIntangibleAssets |
On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. | text | 750.0 | monetaryItemType | text: <entity> 750.0 </entity> <entity type> monetaryItemType </entity type> <context> On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. | text | 100.0 | monetaryItemType | text: <entity> 100.0 </entity> <entity type> monetaryItemType </entity type> <context> On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. | text | 4.9 | monetaryItemType | text: <entity> 4.9 </entity> <entity type> monetaryItemType </entity type> <context> On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. </context> | us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding |
On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. | text | 95.1 | monetaryItemType | text: <entity> 95.1 </entity> <entity type> monetaryItemType </entity type> <context> On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. </context> | us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity |
On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. | text | 745.1 | monetaryItemType | text: <entity> 745.1 </entity> <entity type> monetaryItemType </entity type> <context> On October 8, 2021, we entered into a five-year , $ 750.0 million, revolving loan and standby letter of credit facility agreement (“Revolving Credit Facility”) of which $ 100.0 million can be issued as letters of credit. As of December 31, 2024, we have issued two letters of credit, one of which is denominated in a foreign currency, for an aggregate of $ 4.9 million, which reduced the letter of credit borrowings available under the Revolving Credit Facility to $ 95.1 million. The aggregate available balance under the Revolving Credit Facility was $ 745.1 million as of December 31, 2024. </context> | us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity |
On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. | text | 0.5 | percentItemType | text: <entity> 0.5 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. | text | 1.0 | percentItemType | text: <entity> 1.0 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. | text | 1.25 | percentItemType | text: <entity> 1.25 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. | text | 0.15 | percentItemType | text: <entity> 0.15 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, we amended the terms of the Revolving Credit Facility to replace LIBOR with Term SOFR as the interest rate benchmark. Under the amended terms of the Revolving Credit Facility, borrowings can be either ABR Loans, Term Benchmark Loans, or SONIA Loans. Outstanding ABR Loans bear interest at a rate equal to the greatest of (A) the Prime Rate, (B) the NYFRB Rate plus 0.5 %, (C) the Adjusted Term SOFR Rate plus 1.0 %, or (D) 1.0 % (each as defined in the amended Revolving Credit Facility), in each case plus 0.25 %. Outstanding Term Benchmark Loans bear interest at the Adjusted Term SOFR Rate, the Adjusted EURIBOR Rate, or the Adjusted AUD Rate (each as defined in the amended Revolving Credit Facility), as applicable, in each case, plus 1.25 %. Outstanding SONIA Loans bear interest at a rate equal to the Adjusted Daily Simple SONIA (as such term is defined in the amended Revolving Credit Facility) plus 1.25 %. We are required to pay a quarterly commitment fee that accrues at 0.15 % per annum on the unused portion of the aggregate commitments under the credit facility. </context> | us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage |
We enter into contracts with non-cancellable purchase obligations, primarily related to third-party cloud infrastructure agreements under which we are granted access to certain cloud services. During the year ended December 31, 2024, we signed addenda to our cloud services agreements. We are committed under these arrangements to spend at least $ 480.0 million through September 2026, before consideration of any credits that may be earned during the term. We have met all minimum purchase commitments under these agreements during the periods presented. | text | 480.0 | monetaryItemType | text: <entity> 480.0 </entity> <entity type> monetaryItemType </entity type> <context> We enter into contracts with non-cancellable purchase obligations, primarily related to third-party cloud infrastructure agreements under which we are granted access to certain cloud services. During the year ended December 31, 2024, we signed addenda to our cloud services agreements. We are committed under these arrangements to spend at least $ 480.0 million through September 2026, before consideration of any credits that may be earned during the term. We have met all minimum purchase commitments under these agreements during the periods presented. </context> | us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount |
Immediately prior to the completion of our IPO, all of our then-outstanding shares of convertible preferred stock were automatically converted into 5,104,017 and 67,917,432 shares of our Class A and Class B common stock, respectively. | text | 5104017 | sharesItemType | text: <entity> 5104017 </entity> <entity type> sharesItemType </entity type> <context> Immediately prior to the completion of our IPO, all of our then-outstanding shares of convertible preferred stock were automatically converted into 5,104,017 and 67,917,432 shares of our Class A and Class B common stock, respectively. </context> | us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities |
Immediately prior to the completion of our IPO, all of our then-outstanding shares of convertible preferred stock were automatically converted into 5,104,017 and 67,917,432 shares of our Class A and Class B common stock, respectively. | text | 67917432 | sharesItemType | text: <entity> 67917432 </entity> <entity type> sharesItemType </entity type> <context> Immediately prior to the completion of our IPO, all of our then-outstanding shares of convertible preferred stock were automatically converted into 5,104,017 and 67,917,432 shares of our Class A and Class B common stock, respectively. </context> | us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities |
B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. | text | 4.67 | perShareItemType | text: <entity> 4.67 </entity> <entity type> perShareItemType </entity type> <context> B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. </context> | us-gaap:TemporaryEquityLiquidationPreferencePerShare |
B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. | text | 5.93 | perShareItemType | text: <entity> 5.93 </entity> <entity type> perShareItemType </entity type> <context> B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. </context> | us-gaap:TemporaryEquityLiquidationPreferencePerShare |
B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. | text | 6.26 | perShareItemType | text: <entity> 6.26 </entity> <entity type> perShareItemType </entity type> <context> B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. </context> | us-gaap:TemporaryEquityLiquidationPreferencePerShare |
B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. | text | 15.77 | perShareItemType | text: <entity> 15.77 </entity> <entity type> perShareItemType </entity type> <context> B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. </context> | us-gaap:TemporaryEquityLiquidationPreferencePerShare |
B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. | text | 21.69 | perShareItemType | text: <entity> 21.69 </entity> <entity type> perShareItemType </entity type> <context> B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. </context> | us-gaap:TemporaryEquityLiquidationPreferencePerShare |
B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. | text | 42.47 | perShareItemType | text: <entity> 42.47 </entity> <entity type> perShareItemType </entity type> <context> B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. </context> | us-gaap:TemporaryEquityLiquidationPreferencePerShare |
B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. | text | 61.79 | perShareItemType | text: <entity> 61.79 </entity> <entity type> perShareItemType </entity type> <context> B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1, and Series A and Series A-1 of their full preferential amounts, our remaining assets would be distributed ratably among the holders of Class A common stock and Class B common stock in proportion to the number of shares of common stock held by each holder. The preferential amounts per share of the Series A, Series A-1, Series B, Series C, Series D, Series D-1, Series E, Series F, and Series F-1 convertible preferred stock were approximately $ 4.67 , $ 5.93 , $ 6.26 , $ 15.77 , $ 21.69 , $ 21.69 , $ 42.47 , $ 61.79 , and $ 61.79 as of December 31, 2023. </context> | us-gaap:TemporaryEquityLiquidationPreferencePerShare |
We have three classes of authorized common stock — Class A, Class B, and Class C common stock. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion rights. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 10 votes per share. Shares of Class B common stock may be converted to Class A common stock at any time at the option of the stockholder. In addition, each share of Class B common stock will convert automatically into one share of Class A common stock (i) upon any transfer, except for certain permitted transfers set forth in the Restated Certificate, including transfers to family members, certain trusts for estate planning purposes, entities under common control with or controlled by such holder of our Class B common stock, and with respect to Advance Magazine Publishers Inc., or any Advance Entity (as defined in the Restated Certificate), or (ii) upon the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 7.5 % of the aggregate number of then-outstanding shares of our Class A and Class B common stock. Once converted into Class A common stock, the Class B common stock will not be reissued. In connection with our IPO, the Restated Certificate became effective, which authorized 100,000,000 shares of Class C common stock. Each holder of Class C common stock is entitled to no votes per share. | text | 100000000 | sharesItemType | text: <entity> 100000000 </entity> <entity type> sharesItemType </entity type> <context> We have three classes of authorized common stock — Class A, Class B, and Class C common stock. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion rights. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 10 votes per share. Shares of Class B common stock may be converted to Class A common stock at any time at the option of the stockholder. In addition, each share of Class B common stock will convert automatically into one share of Class A common stock (i) upon any transfer, except for certain permitted transfers set forth in the Restated Certificate, including transfers to family members, certain trusts for estate planning purposes, entities under common control with or controlled by such holder of our Class B common stock, and with respect to Advance Magazine Publishers Inc., or any Advance Entity (as defined in the Restated Certificate), or (ii) upon the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 7.5 % of the aggregate number of then-outstanding shares of our Class A and Class B common stock. Once converted into Class A common stock, the Class B common stock will not be reissued. In connection with our IPO, the Restated Certificate became effective, which authorized 100,000,000 shares of Class C common stock. Each holder of Class C common stock is entitled to no votes per share. </context> | us-gaap:CommonStockSharesAuthorized |
In connection with our IPO, the Restated Certificate became effective, which authorized 100,000,000 shares of undesignated preferred stock. Our board of directors has the discretion to determine the rights, preferences, privileges, and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges, and liquidation preferences, of each series of preferred stock. | text | 100000000 | sharesItemType | text: <entity> 100000000 </entity> <entity type> sharesItemType </entity type> <context> In connection with our IPO, the Restated Certificate became effective, which authorized 100,000,000 shares of undesignated preferred stock. Our board of directors has the discretion to determine the rights, preferences, privileges, and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges, and liquidation preferences, of each series of preferred stock. </context> | us-gaap:PreferredStockSharesAuthorized |
In February 2024, our board of directors adopted the 2024 Incentive Award Plan (the “2024 Plan”), which became effective in connection with the IPO. Under the 2024 Plan, 31,747,592 shares of our Class A common stock were reserved for issuance pursuant to a variety of stock-based compensation awards, including stock options, stock appreciation rights, restricted stock awards, RSU awards, performance bonus awards, performance stock unit awards, dividend equivalents, or other stock or cash based awards. The 2024 Plan also includes shares of our Class A common stock that remained available for grant of future awards under our 2017 Equity Incentive and Grant Plan (as amended, the "2017 Plan") at the time the 2024 Plan became effective. Following the effective date of our IPO, the number of shares reserved for issuance under the 2024 Plan will increase by an annual increase on the first day of each fiscal year beginning in 2025 and ending in 2034, equal to the lesser of (A) 5 % of the shares of common stock outstanding (on an as converted basis) on the last day of the immediately preceding year and (B) such smaller number of shares of stock as determined by our board of directors; provided, however, that no more than 185,661,778 shares of stock may be issued upon the exercise of incentive stock options. | text | 31747592 | sharesItemType | text: <entity> 31747592 </entity> <entity type> sharesItemType </entity type> <context> In February 2024, our board of directors adopted the 2024 Incentive Award Plan (the “2024 Plan”), which became effective in connection with the IPO. Under the 2024 Plan, 31,747,592 shares of our Class A common stock were reserved for issuance pursuant to a variety of stock-based compensation awards, including stock options, stock appreciation rights, restricted stock awards, RSU awards, performance bonus awards, performance stock unit awards, dividend equivalents, or other stock or cash based awards. The 2024 Plan also includes shares of our Class A common stock that remained available for grant of future awards under our 2017 Equity Incentive and Grant Plan (as amended, the "2017 Plan") at the time the 2024 Plan became effective. Following the effective date of our IPO, the number of shares reserved for issuance under the 2024 Plan will increase by an annual increase on the first day of each fiscal year beginning in 2025 and ending in 2034, equal to the lesser of (A) 5 % of the shares of common stock outstanding (on an as converted basis) on the last day of the immediately preceding year and (B) such smaller number of shares of stock as determined by our board of directors; provided, however, that no more than 185,661,778 shares of stock may be issued upon the exercise of incentive stock options. </context> | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
we granted our Chief Executive Officer 2,990,511 | text | 2990511 | sharesItemType | text: <entity> 2990511 </entity> <entity type> sharesItemType </entity type> <context> we granted our Chief Executive Officer 2,990,511 </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
As of December 31, 2024, we had RSUs and RSAs outstanding for 11,344,247 common shares, of which 10,746,145 relate to Class A common stock and 598,102 relate to Class B common stock. The weighted-average grant date fair value of RSUs and RSAs granted during the years ended December 31, 2024, 2023, and 2022 was $ 56.96 , $ 26.71 , and $ 37.88 , respectively. The total fair value of RSUs and RSAs vested during the years ended December 31, 2024, 2023, and 2022 was $ 766.8 million, $ 27.9 million, and $ 33.4 million, respectively. Total unrecognized stock-based compensation expense related to RSUs and RSAs was $ 292.2 million as of December 31, 2024 and is expected to be recognized over a weighted-average period of 1.41 years. | text | 11344247 | sharesItemType | text: <entity> 11344247 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, we had RSUs and RSAs outstanding for 11,344,247 common shares, of which 10,746,145 relate to Class A common stock and 598,102 relate to Class B common stock. The weighted-average grant date fair value of RSUs and RSAs granted during the years ended December 31, 2024, 2023, and 2022 was $ 56.96 , $ 26.71 , and $ 37.88 , respectively. The total fair value of RSUs and RSAs vested during the years ended December 31, 2024, 2023, and 2022 was $ 766.8 million, $ 27.9 million, and $ 33.4 million, respectively. Total unrecognized stock-based compensation expense related to RSUs and RSAs was $ 292.2 million as of December 31, 2024 and is expected to be recognized over a weighted-average period of 1.41 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber |
As of December 31, 2024, we had RSUs and RSAs outstanding for 11,344,247 common shares, of which 10,746,145 relate to Class A common stock and 598,102 relate to Class B common stock. The weighted-average grant date fair value of RSUs and RSAs granted during the years ended December 31, 2024, 2023, and 2022 was $ 56.96 , $ 26.71 , and $ 37.88 , respectively. The total fair value of RSUs and RSAs vested during the years ended December 31, 2024, 2023, and 2022 was $ 766.8 million, $ 27.9 million, and $ 33.4 million, respectively. Total unrecognized stock-based compensation expense related to RSUs and RSAs was $ 292.2 million as of December 31, 2024 and is expected to be recognized over a weighted-average period of 1.41 years. | text | 10746145 | sharesItemType | text: <entity> 10746145 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, we had RSUs and RSAs outstanding for 11,344,247 common shares, of which 10,746,145 relate to Class A common stock and 598,102 relate to Class B common stock. The weighted-average grant date fair value of RSUs and RSAs granted during the years ended December 31, 2024, 2023, and 2022 was $ 56.96 , $ 26.71 , and $ 37.88 , respectively. The total fair value of RSUs and RSAs vested during the years ended December 31, 2024, 2023, and 2022 was $ 766.8 million, $ 27.9 million, and $ 33.4 million, respectively. Total unrecognized stock-based compensation expense related to RSUs and RSAs was $ 292.2 million as of December 31, 2024 and is expected to be recognized over a weighted-average period of 1.41 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.